Investment
Features
FeesSafety
Academy
More
Pluang+

Compare MP Materials (MP) vs TransMedics Group Inc (TMDX) Price & Performance

MP MaterialsTrade
TransMedics Group IncTrade

Price performance (Past 24H)

Key statistics

MP Materials vs TransMedics Group Inc — how do they compare? MP Materials trades at $54.32 (market cap $9.86B), while TransMedics Group Inc trades at $85.89 (market cap $3.06B). The key difference: MP Materials is far larger — about 3.2× TransMedics Group Inc's market cap. Which is the better fit depends on your goals.

MPTMDX
Market Cap
$9.86B$3.06B
Sector
IndustrialsTechnology
52-Week High
$98.65$150.42
52-Week Low
$38.10$61.99
Enterprise Value
$9.34B$3.46B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

MP Materials

No Aura AI signal available yet.

TransMedics Group Inc

TransMedics Group (TMDX) trades at $88.27, down 1.9% on the day, with a bullish technical signal from moving averages but mixed earnings results. The company reported strong revenue growth to $605.49M in 2025, with a net income margin of 22.69%, though profitability is expected to moderate in 2026. Recent news highlights ongoing legal investigations into fiduciary duties alongside positive coverage of growth initiatives in kidney transplantation and European expansion.

The stock presents a growth opportunity with analyst consensus pointing to a $99.57 price target, but risks include margin pressure from heavy investments and legal uncertainties. Earnings misses in recent quarters and a projected decline in net income for 2026 warrant caution, though institutional interest remains with a bullish rating from 69% of analysts.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About MP Materials

MP Materials mines, refines, and manufactures rare earth materials and magnets in the United States. Its products are used in transportation, energy, robotics, defense, and aerospace applications.

Read more on MP

About TransMedics Group Inc

TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.

Read more on TMDX